Bio Pharma Dive
APRIL 11, 2022
Pfizer is bringing in former Lowe's and CVS Health executive David Denton, while Moderna hired Jorge Gomez, previously CFO at Cardinal Health. Both take the reins as their new companies face strategic questions.
pharmaphorum
APRIL 11, 2022
Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full value of medicines. Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. As an oncology trained medical doctor who practiced in the UK NHS for 10 years, I have seen the benefits first-hand, as patients live longer lives, free from symp
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 11, 2022
This year's meeting on early cancer research featured promising study results from German biotechs BioNTech and Affimed as well as details from a "practice-changing" lung cancer trial.
pharmaphorum
APRIL 11, 2022
In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation Fund), pharmaphorum discusses the recent announcement of the closing of a $25 million Series A financing round to scale up the innovative VivoSense® software, which uses wearable sensor data in clinical trials, and for the development of novel digital biomarkers.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
APRIL 11, 2022
Leading through a pandemic is no easy feat but this pharmaceutical company's CEO led his organization not only from his head, but also from his heart.
pharmaphorum
APRIL 11, 2022
GripAble has raised $11 million in first-round financing that will be used to advance its digital health approach to rehabilitation for people with neurological and musculoskeletal conditions on the international stage. The London, UK-based company has developed a platform that combines a hand-held sensor, gamified mobile app software, and telehealth consultations with therapists, which is designed to entertain users while they train at home.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioPharma Reporter
APRIL 11, 2022
Lonza has added new integrated capabilities in cell binding, cell separation, and bead removal to its closed, automated, and scalable platform for personalized therapy manufacturing.
Bio Pharma Dive
APRIL 11, 2022
As medical affairs continues to invest in systems and data it can quickly become overwhelming to keep up with it all.
Scienmag
APRIL 11, 2022
Milling rice to separate the grain from the husks produces about 100 million tons of rice husk waste globally each year. Scientists searching for a scalable method to fabricate quantum dots have developed a way to recycle rice husks to create the first silicon quantum dot (QD) LED light. Their new method transforms agricultural waste […].
Bio Pharma Dive
APRIL 11, 2022
Licensing deals with pharmaceutical companies were an early strategy for digital health companies, but not all of them have lasted.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
APRIL 11, 2022
The researchers behind an energy system that makes it possible to capture solar energy, store it for up to eighteen years and release it when and where it is needed have now taken the system a step further. After previously demonstrating how the energy can be extracted as heat, they have now succeeded in getting […].
NY Times
APRIL 11, 2022
The chemical derived from psychedelic mushrooms helped alleviate symptoms of depression and generated detectable neural responses that lasted weeks.
Scienmag
APRIL 11, 2022
COLUMBIA, Mo. — As an assistant teaching professor in the MU Sinclair School of Nursing, Stefanie Birk knows there are nursing students unsure of how to talk with people hesitant about getting a COVID-19 vaccine. Being a public health nurse herself, Birk has been in similar situations and is passionate about equipping the next generation […].
Pharma Times
APRIL 11, 2022
The biologics development and manufacturing facility is currently under construction near Oxford, UK
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
APRIL 11, 2022
NEW YORK – A collaboration between researchers at Columbia and the Icahn School of Medicine is embarking on a project that will generate comprehensive atlases of entire human brains and all their 180+ billion cells. This kind of data can help uncover how the structure and organization of the brain give rise to behavior, emotion […].
NY Times
APRIL 11, 2022
A late-stage trial was halted after strong early results, according to the company, but the data have not yet been published or peer-reviewed.
Scienmag
APRIL 11, 2022
New research led by the University of East Anglia (UEA) highlights the areas in Europe and North Africa where the construction of wind turbines or power lines is likely to increase the risk of death for migrating birds. Credit: Jethro Gauld New research led by the University of East Anglia (UEA) highlights the areas in […].
Pharma Times
APRIL 11, 2022
Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
APRIL 11, 2022
Jacobo Arango, an environmental biologist at the Tropical Forages Program at the Alliance of Bioversity and CIAT and an author of the mitigation chapter of the Intergovernmental Panel on Climate Change (IPCC) report released on April 4, 2022, said it was encouraging to see in the report that some countries are on track to meet their […].
Drug Channels
APRIL 11, 2022
Informa Connect's Life Sciences Commercial Contracts & Chargebacks 2022 Hybrid. May 24-25, 2022 | Philadelphia, PA www.informaconnect.com/contracts-chargebacks. Save 10% by using code 22DC10. The Life Sciences Commercial Contracts and Chargebacks conference returns as a hybrid event May 24-25 with the options of attending in-person in Philadelphia or virtually.
Scienmag
APRIL 11, 2022
FRANKFURT. SARS-CoV-2, the coronavirus that causes COVID-19, needs its spike proteins to dock onto proteins (ACE receptors) on the surface of the host cells. Before this docking is possible, parts of the spike protein have to be cleaved by host cell’s enzymes called proteases. In 2020, a scientific team led by Professor Jindrich Cinatl (Goethe […].
BioPharma Reporter
APRIL 11, 2022
BioNTech is teaming up with Matinas BioPharma in a research collaboration to explore novel formulations for mRNA vaccines, including oral vaccines.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
APRIL 11, 2022
Rhesus macaques are able to perceive their own heartbeats, according to a new study from the California National Primate Research Center at the University of California, Davis, and Royal Holloway, University of London. The research, published April 11 in Proceedings of the National Academy of Sciences creates a first-of-its-kind animal model of interoception.
pharmaphorum
APRIL 11, 2022
Affimed says new data from a phase 1/2 trial of its natural killer (NK) cell engager therapy AFM13 provide further evidence of its efficacy in treating CD30+ Hodgkin and non-Hodgkin lymphoma patients, although not for the version that will likely be filed for approval. The MD Anderson study now has data from 19 patients, with all responding and 13 (62%) having a complete response after treatment with AFM13.
Scienmag
APRIL 11, 2022
An international team of astronomers have used ground-based telescopes, including the European Southern Observatory’s Very Large Telescope (ESO’s VLT), to track Neptune’s atmospheric temperatures over a 17-year period. They found a surprising drop in Neptune’s global temperatures followed by a dramatic warming at its south pole. Credit: [Credit must be given to the creator and […].
Drug Patent Watch
APRIL 11, 2022
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are twenty-nine patents protecting this drug. This drug…. The post New patent for Amicus Therap drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
APRIL 11, 2022
FOR IMMEDIATE RELEASE Adding the immunotherapy drug nivolumab to chemotherapy before surgery (neoadjuvant) for patients with operable non-small cell lung cancer (NSCLC) — the leading cause of cancer deaths worldwide — reduced the risk of recurrence of the cancer or death by more than one-third, according to results from the phase III CheckMate-816 trial.
Drug Patent Watch
APRIL 11, 2022
Annual Drug Patent Expirations for BRILINTA Brilinta is a drug marketed by Astrazeneca and is included in one NDA. It is available from two suppliers. There are three patents protecting…. The post New patent for Astrazeneca drug BRILINTA appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 11, 2022
The strength of a brain circuit predicts the ability of children to learn math, according to research recently published in JNeurosci. Tutoring regimes designed to target the circuit may improve learning outcomes for children across a range of abilities. Credit: Chang et al., JNeurosci 2022 The strength of a brain circuit predicts the ability of […].
Drug Patent Watch
APRIL 11, 2022
Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
317 
Let's personalize your content